fda food and drug administration

FDA rehires staff to its medical devices division

FDA moves to rehire medical device, food safety and other staffers fired days earlier

Barely a week after mass firings at the Food and Drug Administration, some probationary staffers received unexpected news over the weekend: The government wants them back. Beginning Friday night, FDA employees overseeing medical devices,

Yahoo · 10h

FDA rehires staff to its medical devices division after mass layoffs

The Trump administration is reinstating some employees in the Food and Drug Administration's medical devices division after dozens were laid off as part of a government-wide cost-cutting initiative led by billionaire Elon Musk and his Department of Government Efficiency,

Penn Live · 14h

FDA rehires medical device staffers fired only days earlier

Like other agencies, the FDA terminations went to employees in their probationary period, typically the first two years of federal employment. But that approach resulted in the te

Hosted on MSN · 6d

Trump Cuts Hit FDA Employees in Tobacco, Food Safety and Medical Devices

Probationary employees across the FDA received notices Saturday evening that their jobs were being eliminated, according to three FDA staffers who spoke to The Associated Press on

Pfizer hires ex-FDA drug chief

The Hill on MSN · 15h

Pfizer hires ex-FDA drug chief as top doctor

The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the company announced Monday. Patrizia Cavazzoni was formerly director of

Reuters on MSN · 16h

Pfizer names former FDA director as chief medical officer

Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief medical officer, bringing back an industry veteran to lead its regulatory and drug safety operations.

Seeking Alpha on MSN · 16h

Pfizer taps former FDA drug chief as chief medical officer

Pfizer (NYSE:PFE) has tapped Patrizia Cavazzoni, the former head of drug regulation at the FDA, as its new chief medical officer. Cavazzoni was most recently director of the Center for Drug Evaluation and Research (CDER) at the U.

Drug compounders sue FDA over semaglutide status

AOL · 2d

FDA announces end to Wegovy and Ozempic drug shortages, but it could mean higher prices

The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is over.

Reuters · 15h

Drug compounders sue US FDA over removal of Wegovy, Ozempic from shortage list

Drug compounders on Monday sued the U.S. Food and Drug Administration over its decision last week to remove Novo Nordisk's weight loss and diabetes drugs Wegovy and Ozempic from its shortage list, a move that will sharply curtail the compounders' ability to sell cheaper versions of the drugs.

Seeking Alpha on MSN · 11h

Drug compounders sue FDA over semaglutide status: report

Makers of copycat versions of Novo Nordisk's (NVO) popular weight-loss drug semaglutide, also known as Ozempic and Wegovy, are suing the FDA for removing the GLP-1 medication from its shortage list. The Outsourcing Facilities Association,

Medtronic, Parkinson's disease and FDA

Reuters · 20h

US FDA approves Medtronic's medical device for Parkinson's disease

The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with Parkinson's disease, the medical device maker said on Monday.

MarketWatch · 21h

Medtronic Parkinson's Disease Brain Stimulation System Gets FDA Approval

Medtronic said the Food and Drug Administration approved a brain stimulation system for people afflicted with Parkinson's disease. The medical technology company said the regulator approved BrainSense Adaptive deep brain stimulation and BrainSense Electrode Identifier.

Minneapolis Star Tribune on MSN · 9h

In Parkinson’s fight, Medtronic’s first-in-the-world adaptive therapy feature wins FDA approval

After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive technology personalizing treatment of Parkinson’s symptoms using advanced stimulation deep in the brain.

How the FDA's approval for food additives works, and why experts say a loophole allows companies to bypass it

Experts say that for decades, a legal loophole has allowed companies to include chemical additives that could be potentially ...

STAT1d

Trump administration rehires some FDA employees it fired

WASHINGTON — The Trump administration has started quietly rehiring some of the Food and Drug Administration employees it ...

8hon MSN

FDA delays when a final rule on what foods can be labeled as 'healthy' goes into effect

The US Food and Drug Administration's new standards for foods before they can be labeled as "healthy" on their packaging will go into effect about two months later than planned.

Insight: Smokescreen: some vape firms pivot after FDA crackdown

Some e-cigarette companies targeted by U.S. authorities have altered their business model or changed their corporate ...

Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

6don MSN

FDA To Review Teva and Alvotech Drug That Could Compete With Regeneron's Eylea

Key Takeaways Teva Pharmaceutical Industries and partner Alvotech said the Food and Drug Administration agreed to review ...

4don MSN

Top FDA food safety official's resignation letter warns firings will backfire on RFK Jr.

James Jones resigned as FDA deputy commissioner and said the Trump administration's "indiscriminate" job cuts show "disdain for the very people necessary to implement your agenda." ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results